HSHHSH Health Technology Supplier Hub
Home › Suppliers › Beckman Coulter

Beckman Coulter

HQ United States · North America

Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.

At a glance

Financial health
Band: Strong
Customer rating
No reviews yet

Financial health

Band: StrongOwned by Danaher (DHR)

Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.

Figures cover the whole listed group, not this business alone.

Source: official results release · Year ended 2025-12-31 · Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.

YearRevenueGrowthOperating profitNet incomeCovers
FY2025US$24.6bn+3.0%US$4.7bnUS$3.6bnDanaher group

Products & services

Products not yet catalogued.

Financial

Parent Danaher (DHR) group FY2025 revenue $24.57bn (+3.0%); operating margin 19.1%; net income $3.60bn.

Figures cover the whole listed group, not this business alone.

Researched 8 Nov 2026

Adverse media

No adverse media involving Beckman Coulter found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Cyber & information governance

Feb 2025: A medium-severity vulnerability (CVE-2025-0941) was published for Beckman Coulter Life Sciences' MET ONE 3400+ particle counter, which could store credentials in plain text in rare conditions. No breaches or regulator actions found. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Mar 2026: The FDA posted a Class 2 recall of one lot of Beckman Coulter MicroScan Neg MIC 56 panels, started by the firm in Jul 2025, owing to likely contamination in a test well.

Researched 10 Nov 2026

Contract performance

Apr 2025: University Hospitals of North Midlands NHS Trust gave notice of a pathology managed service award to Beckman Coulter for its Leighton and Macclesfield sites; in Oct 2025 GOSH directly awarded it a £272k lab automation contract.

Researched 10 Nov 2026

Competitors

No competitors linked yet.

Customer reviews

No reviews yet